FIA
EVH icon

FNY Investment Advisers’s Evolent Health EVH Stock Holding History

FNY Investment Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,256
Closed -$5K – 879
2025
Q4 		$5K Buy
1,256
+1,031
+458% +$5.73K ﹤0.01% 730
2025
Q3 		$1K Buy
+225
New +$2.18K ﹤0.01% 1134

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPA
Rock Point Advisors Burlington, Vermont $409M AUM 30.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BSP
Benefit Street Partners New York $69.6M AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

FNY Investment Advisers's EVH Position: Q2 2026 in Review

FNY Investment Advisers held its Evolent Health (EVH) position steady in Q2 2026 at 5,000 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #494.

FNY Investment Advisers first reported a position in EVH in Q4 2018 and has held it in 5 quarters since. The position peaked at $191K in Q3 2025. 64 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • FNY Investment Advisers held 5,000 shares of Evolent Health worth $27K as of Q2 2026.
  • FNY Investment Advisers left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #494 holding.
  • FNY Investment Advisers first reported a position in Evolent Health in Q4 2018 and has held it in 5 quarters since.
  • FNY Investment Advisers's Evolent Health position peaked at $191K in Q3 2025.
  • 64 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.